Phase I/II clinical study to evaluate the safety and efficacy of the infusion of RP-L102

• Research type

  Research Study

• Full title

  Publication of this data is currently deferred.

• IRAS ID

  1007733

• Contact name

  Publication of this data is currently deferred.

• Contact email

  Publication of this data is currently deferred.

• Sponsor organisation

  Rocket Pharmaceuticals Inc.

• Eudract number

  Publication of this data is currently deferred.

• Clinicaltrials.gov Identifier

  Publication of this data is currently deferred.

• Research summary

  Publication of this data is currently deferred.

• REC name

  South Central - Oxford A Research Ethics Committee

• REC reference

  23/SC/0360

• Date of REC Opinion

  13 Dec 2023

• REC opinion

  Further Information Favourable Opinion